Correlation Between Day One and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Day One and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Day One and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Mineralys Therapeutics,.
Diversification Opportunities for Day One and Mineralys Therapeutics,
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Day and Mineralys is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Day One i.e., Day One and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Day One and Mineralys Therapeutics,
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.52 times less risky than Mineralys Therapeutics,. The stock trades about -0.12 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 1,194 in Mineralys Therapeutics, Common on December 4, 2024 and sell it today you would lose (300.00) from holding Mineralys Therapeutics, Common or give up 25.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Day One Biopharmaceu |
| Mineralys Therapeutics, |
Day One and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Mineralys Therapeutics,
The main advantage of trading using opposite Day One and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Mineralys Therapeutics, vs. Direct Line Insurance | Mineralys Therapeutics, vs. Pekin Life Insurance | Mineralys Therapeutics, vs. Essent Group | Mineralys Therapeutics, vs. NetSol Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |